Search Results - Seth Russell
- Showing 1 - 8 results of 8
-
1
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment by Lindsey E. Fish, Samantha C. Roberts, Tellen D. Bennett, Nichole E. Carlson, Mika K. Hamer, Bethany M. Kwan, Seth Russell, Adane F. Wogu, Matthew K. Wynia, Adit A. Ginde
Published in PLoS ONE (2025-01-01)Get full text
Article -
2
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment. by Lindsey E Fish, Samantha C Roberts, Tellen D Bennett, Nichole E Carlson, Mika K Hamer, Bethany M Kwan, Seth Russell, Adane F Wogu, Matthew K Wynia, Adit A Ginde
Published in PLoS ONE (2025-01-01)Get full text
Article -
3
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase by Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Adit A. Ginde
Published in International Journal of Infectious Diseases (2023-03-01)Get full text
Article -
4
Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5 by Kyle C. Molina, Victoria Kennerley, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde
Published in International Journal of Infectious Diseases (2023-07-01)Get full text
Article -
5
Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5 by Kyle C. Molina, Brandon J. Webb, Victoria Kennerley, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, David A. Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde
Published in BMC Infectious Diseases (2024-08-01)Get full text
Article -
6
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19 by Sarah K. Wendel, Adane F. Wogu, Nichole E. Carlson, Laurel Beaty, Tellen D. Bennett, Kelly Bookman, David A. Mayer, Sean S. Michael, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Richard D. Zane, Adit A. Ginde
Published in Journal of the American College of Emergency Physicians Open (2024-02-01)Get full text
Article -
7
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients by David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Published in BMC Infectious Diseases (2022-11-01)Get full text
Article -
8
Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study by Elaine L. Hill, Hemalkumar B. Mehta, Suchetha Sharma, Klint Mane, Sharad Kumar Singh, Catherine Xie, Emily Cathey, Johanna Loomba, Seth Russell, Heidi Spratt, Peter E. DeWitt, Nariman Ammar, Charisse Madlock-Brown, Donald Brown, Julie A. McMurry, Christopher G. Chute, Melissa A. Haendel, Richard Moffitt, Emily R. Pfaff, Tellen D. Bennett, on behalf of the N3C Consortium, and the RECOVER Consortium
Published in BMC Public Health (2023-10-01)Get full text
Article
